Loading...

Data on migration of the non-invasive breast cancer cell line, MCF-7 treated with Bevacizumab using Real Time Cell Analyzer (RTCA)

Bevacizumab or Avastin® (Av), the recombinant antibody targeting VEGF, improves progression-free but not overall survival of metastatic breast cancer patients due to development of Av resistance. We showed that Av-therapy-induced inflammatory microenvironment contributes to the refractoriness to Av...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Data Brief
Main Authors: EL-Hajjar, Layal, Shaito, Abdullah, Jalaleddine, Nour, Zibara, Kazem, Kazan, Jalal M., El-Saghir, Jamal, El-Sabban, Marwan
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6327074/
https://ncbi.nlm.nih.gov/pubmed/30671510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dib.2018.12.059
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!